These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11580905)

  • 1. Hemopexin: a review of biological aspects and the role in laboratory medicine.
    Delanghe JR; Langlois MR
    Clin Chim Acta; 2001 Oct; 312(1-2):13-23. PubMed ID: 11580905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis.
    Tolosano E; Fagoonee S; Hirsch E; Berger FG; Baumann H; Silengo L; Altruda F
    Blood; 2002 Dec; 100(12):4201-8. PubMed ID: 12393471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme scavenging and the other facets of hemopexin.
    Tolosano E; Fagoonee S; Morello N; Vinchi F; Fiorito V
    Antioxid Redox Signal; 2010 Feb; 12(2):305-20. PubMed ID: 19650691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of serum hemopexin in fulminant rhabdomyolysis. Evidence for an interaction of hemopexin with myoglobin-derived heme.
    Adornato BT; Kagen LJ; Garver FA; Engel WK
    Arch Neurol; 1978 Aug; 35(8):547-8. PubMed ID: 666618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the receptor scavenging hemopexin-heme complexes.
    Hvidberg V; Maniecki MB; Jacobsen C; Højrup P; Møller HJ; Moestrup SK
    Blood; 2005 Oct; 106(7):2572-9. PubMed ID: 15947085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.
    Vinchi F; Gastaldi S; Silengo L; Altruda F; Tolosano E
    Am J Pathol; 2008 Jul; 173(1):289-99. PubMed ID: 18556779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin.
    Hunt RC; Handy I; Smith A
    J Cell Physiol; 1996 Jul; 168(1):81-6. PubMed ID: 8647926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.
    Smith A; McCulloh RJ
    Front Physiol; 2015; 6():187. PubMed ID: 26175690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemopexin from four species inhibits the association of heme with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors.
    Taketani S; Immenschuh S; Go S; Sinclair PR; Stockert RJ; Liem HH; Muller Eberhard U
    Hepatology; 1998 Mar; 27(3):808-14. PubMed ID: 9500711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.
    Yang Z; Philips JD; Doty RT; Giraudi P; Ostrow JD; Tiribelli C; Smith A; Abkowitz JL
    J Biol Chem; 2010 Sep; 285(37):28874-82. PubMed ID: 20610401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe coordinated trafficking of heme and iron with copper maintain cell homeostasis: modules from the hemopexin system.
    Vanacore R; Eskew JD; Sung L; Davis T; Smith A
    Biometals; 2019 Jun; 32(3):355-367. PubMed ID: 31011852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the histidine residues of hemopexin that coordinate with heme-iron and of a receptor-binding region.
    Morgan WT; Muster P; Tatum F; Kao SM; Alam J; Smith A
    J Biol Chem; 1993 Mar; 268(9):6256-62. PubMed ID: 7681064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice.
    Tolosano E; Hirsch E; Patrucco E; Camaschella C; Navone R; Silengo L; Altruda F
    Blood; 1999 Dec; 94(11):3906-14. PubMed ID: 10572107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of heme-hemopexin in human T-lymphocyte proliferation.
    Smith A; Eskew JD; Borza CM; Pendrak M; Hunt RC
    Exp Cell Res; 1997 May; 232(2):246-54. PubMed ID: 9168799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.
    Vinchi F; Tolosano E
    Oxid Med Cell Longev; 2013; 2013():396527. PubMed ID: 23781294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.
    Graw JA; Mayeur C; Rosales I; Liu Y; Sabbisetti VS; Riley FE; Rechester O; Malhotra R; Warren HS; Colvin RB; Bonventre JV; Bloch DB; Zapol WM
    Circulation; 2016 Sep; 134(13):945-60. PubMed ID: 27515135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases.
    Mehta NU; Reddy ST
    Curr Opin Lipidol; 2015 Oct; 26(5):384-7. PubMed ID: 26339767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cysteine as a spectroscopic probe for determination of heme-scavenging capacity of serum proteins and whole human serum.
    Noé R; Bozinovic N; Lecerf M; Lacroix-Desmazes S; Dimitrov JD
    J Pharm Biomed Anal; 2019 Aug; 172():311-319. PubMed ID: 31085393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
    Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
    Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.